Association of Hypoadiponectinemia With Coronary Artery Disease in Men
By M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, S. Matsumoto, N. Ouchi, Y. Arita, Y. Okamoto, I. Shimomura, H. Hiraoka and 3 more. Arteriosclerosis, Thrombosis and Vascular Biology, 2003
1,292 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/14ce18783b0bcfd6f5f3c00c4c9666dd55886448
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Epidemiology
- F. B. Hu
- Takashi Kadowaki
- Toshimasa Yamauchi
- G. Hotamisligil
- N. Rifai
- P. Ridker
- B. K. Pedersen
- Peter Libby
In Physiology
- F. B. Hu
- E. Rimm
- Toshimasa Yamauchi
- Takashi Kadowaki
- L. Galland
- W. Willett
- Mitchell A. Lazar
- F. B. Hu
Citations in the corpus
- Plasma adiponectin levels and risk of myocardial infarction in men. (2004, result): “Furthermore, this type of nonlinear relationship is consistent with other reports on adiponectin and risk of CHD and type 2 diabetes.(13,43) A single assessment of adiponectin may be susceptible to short-termvariation,whichwouldbias the results toward the null.”
- A review on coronary artery disease, its risk factors, and therapeutics (2019, background): “Dysregulation of the adipocyte‐derived endocrine factors occurring in overnutrition has been assumed to participate in the development of atherosclerosis (Kumada et al., 2003).”
- Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. (2003, background): “tients with a broad spectrum of coronary artery disease,(15) and circulating levels of adiponectin are lower in patients with coronary artery disease.(28) Thus, the increased cardiovascular risk of obese persons may be seen as the result, at least in part, of increased inflammatory stimuli and decre”